Involvement and functional impairment of the CD34+CD38-Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8

Blood

Volumn 100, Issue 1, 2002, Pages 259-267

  Nilsson, Lars ^a,b,c,d   Åstrand Grundström, Ingbritt ^a,b,c,d   Anderson, Kristina ^a,b,c,d   Arvidsson, Ingrid ^a,b,c,d   Hokland, Peter ^a,b,c,d   Bryder, David ^a,b,c,d   Kjeldsen, Lars ^a,b,c,d   Johansson, Bertil ^a,b,c,d   Hellström Lindberg, Eva ^a,b,c,d   Hast, Robert ^a,b,c,d   Jacobsen, Sten Eirik W ^a,b,c,d,e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; CHROMOSOME 8; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KARYOTYPE; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGENY; SCID MOUSE; T LYMPHOCYTE; TRISOMY 8;

EID: 0036659925     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0188     Document Type: Article

References (41)

1. Greenberg P. Myelodysplastic syndrome. In: Hoffman R, Benz EJ, Shattil SJ, et al, eds. Hematology, Basic Principles and Practice. Philadelphia, PA: Churchill Livingstone; 2000:1106-1129.
2. Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM. The biology of chronic myeloid leukemia. N Engl J Med. 1999;341:164-172.
3. Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649-1660.
4. Abrahamson G, Boultwood J, Madden J, et al. Clonality of cell populations in refractory anaemia using combined approach of gene loss and x-linked restriction fragment length polymorphismmethylation analyses. Br J Haematol. 1991;79:550-555.
5. van Kamp H, Fibbe WE, Jansen RP, et al. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by x-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood. 1992;80:1774-1780.
6. Kroef MJ, Fibbe WE, Mout R, et al. Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood. 1993;81:1849-1854.
7. Soenen V, Fenaux P, Flactif M, et al. Combined immunophenotyping and in situ hybridization (fiction): a rapid method to study cell lineage involvement in myelodysplastic syndromes. Br J Haematol. 1995;90:701-706.
8. van Lom K, Hagemeijer A, Vandekerckhove F, Smit EM, Lowenberg B. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol. 1996;93:594-600.
9. Bernell P, Jacobsson B, Nordgren A, Hast R. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. Leukemia. 1996;10:662-668.
10. Kroef MJ, Bolk MJ, Muus P, et al. Mosaicism of the 5q deletion as assessed by interphase FISH is a common phenomenon in MDS and restricted to myeloid cells. Leukemia. 1997;11:519-523.
11. Jaju RJ, Jones M, Boultwood J, et al. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q-syndrome. Genes Chromosomes Cancer. 2000;29:276-280.
12. Nilsson L, Åstrand-Grundström I, Arvidsson I, et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood. 2000;96:2012-2021.
13. Miura I, Takahashi N, Kobayashi Y, Saito K, Miura AB. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting. Int J Hematol. 2000;72:310-317.
14. Boultwood J, Wainscoat JS. Clonality in the myelodysplastic syndromes. Int J Hematol. 2001;73:411-415.
15. Gale RE. Evaluation of clonality in myeloid stem-cell disorders. Semin Hematol. 1999;36:361-372.
16. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38-progenitor cells. Blood. 1991;77:1218-1227.
17. Baum CM, Wiessman IL, Tsukamoto AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A. 1992;89:2804-2808.
18. Murray L, DiGiusto D, Chen B, et al, Analysis of human hematopoietic stem cell populations. Blood Cells. 1994;20:364-369.
19. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A. 1996;93:1470-1474.
20. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35-71.
21. Hao QL, Thiemann FT, Petersen D, Smogorzewska EM, Crooks GM. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood. 1996;88:3306-3313.
22. Larochelle A, Vormoor J, Hanenberg H, et al. 96 identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med. 1996;2:1329-1337.
23. Bock TA. Assay systems for hematopoietic stem and progenitor cells. Stem Cells. 1997;15(suppl 1):185-195.
24. Saitoh K, Miura I, Takahashi N, Miura AB. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood. 1998;92:2886-2892.
25. de Souza Fernandez T, Ornellas MH, de Carvalho LO, Tabak D, Abdelhay E. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leuk Res. 2000;24:839-848.
26. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
27. Ramsfjell V, Bryder D, Bjorgvinsdottir H, et al. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)OD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells. Blood. 1999;94:4093-4102.
28. Jacobsson B, Bernell P, Arvidsson I, Hast R. Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears. J Histochem Cytochem. 1996;44:1303-1309.
29. Ramsfjell V, Borge OJ, Cui L, Jacobsen SE. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow progenitor cells: distinct and key interactions with the ligands for c-kit and fit3, and inhibitory effects of TGF-beta and TNF-alpha. J Immunol. 1997;158:5169-5177.
30. Hogge DE, Lansdorp PM, Reid B, Gerhard B, Eaves CJ. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood. 1996;88:3765-3773.
31. Dybedal I, Bryder D, Fossum A, Rusten LS Jacobsen SE. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood. 2001;98:1782-1791.
32. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-737.
33. Craig W, Kay R, Cutler RL, Lansdorp PM. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 1993;177:1331-1342.
34. Holden JT, Geller RB, Farhi DC, et al. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia. Blood. 1995;86:60-65.
35. Inaba T, Shimazaki C, Sumikuma T, et al. Flow cytometric analysis of Thy-1 expression In CD34-positive acute leukemia. Int J Hematol. 1997;66:315-323.
36. Wuchter C, Ratei R, Spahn G, et al, Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping. Haematologica. 2001;86:154-161.
37. Ogawa M. Differentiation and proliferation of hematopoietic stem cells, Blood. 1993;81:2844-2853.
38. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
39. Domen J, Weissman IL. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol Med Today. 1999;5:201-208.
40. de Witte T, Suciu S, Verhoef G, et al. Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. Blood. 2001;98:2326-2331.
41. Miura I, Kobayashi Y, Takahashi N, Saitoh K, Miura AB. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting. Br J Haematol. 2000;110:876-877.